MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial regulators of biological processes, including neuronal function.
• Alzheimer's disease is characterized by the downregulation of miR-132 in neurons.
• Tau pathology is a hallmark of tauopathies and neurodegenerative diseases.

Purpose of the Study:

• To investigate the neuroprotective role of miR-132 in Alzheimer's disease models.
• To elucidate the molecular mechanisms underlying miR-132's protective effects against tau pathology and excitotoxicity.

Main Methods:

• Primary neuronal cultures (mouse and human) and P301S Tau transgenic mice were used.
• Neuronal viability, neurite outgrowth, and long-term potentiation were assessed.
• Levels of total, phosphorylated, acetylated, and cleaved Tau were measured.
• Direct targets of miR-132, including EP300, GSK3β, Rbfox1, Calpain 2, and Caspases 3/7, were identified.

Main Results:

• miR-132 demonstrated significant neuroprotection against amyloid β-peptide and glutamate excitotoxicity in both wild-type and Tau-mutant neurons.
• miR-132 reduced various forms of Tau, promoted neurite elongation and branching, and decreased neuronal death.
• In vivo studies showed that miR-132 attenuated PHF-Tau pathology, neurodegeneration, and enhanced long-term potentiation.
• miR-132 directly regulates key Tau modifiers and proteases involved in neurodegeneration.

Conclusions:

• miR-132 acts as a master regulator of neuronal health and possesses potent neuroprotective properties.
• miR-132 supplementation presents a promising therapeutic avenue for tau-associated neurodegenerative disorders.
• Targeting miR-132 pathways could be a novel strategy for treating Alzheimer's disease and related conditions.